Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.

Embark Veterinary, a US-based canine DNA test provider co-founded by Cornell University faculty, has raised $75m in a series B round led by telecoms and internet group SoftBank’s Vision Fund 2 Investment and financial services group Fidelity’s F-Prime Capital subsidiary also participated in the round, as did SV Angel, Slow Ventures, Freestyle Capital and Third…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.